Pericytes are progenitors for coronary artery smooth muscle

  1. Katharina S Volz
  2. Andrew H Jacobs
  3. Heidi I Chen
  4. Aruna Poduri
  5. Andrew S McKay
  6. Daniel P Riordan
  7. Natalie Kofler
  8. Jan Kitajewski
  9. Irving Weissman
  10. Kristy Red-Horse  Is a corresponding author
  1. Stanford University, United States
  2. Stanford Universitiy, United States
  3. Columbia University Medical Center, United States

Abstract

Epicardial cells on the heart's surface give rise to coronary artery smooth muscle cells (caSMCs) located deep in the myocardium. However, the differentiation steps between epicardial cells and caSMCs are unknown as are the final maturation signals at coronary arteries. Here, we use clonal analysis and lineage tracing to show that caSMCs derive from pericytes, mural cells associated with microvessels, and that these cells are present in adults. During development following the onset of blood flow, pericytes at arterial remodeling sites upregulate Notch3 while endothelial cells express Jagged-1. Deletion of Notch3 disrupts caSMC differentiation. Our data support a model wherein epicardial-derived pericytes populate the entire coronary microvasculature, but differentiate into caSMCs at arterial remodeling zones in response to Notch signaling. Our data is the first demonstration that pericytes are progenitors for smooth muscle, and their presence in adult hearts reveal a new potential cell type for targeting during cardiovascular disease.

Article and author information

Author details

  1. Katharina S Volz

    Stem Cell and Regenerative Medicine PhD Program, Stanford University School of Medicine, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Andrew H Jacobs

    Department of Biological Sciences, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Heidi I Chen

    Department of Biological Sciences, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Aruna Poduri

    Department of Biological Sciences, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Andrew S McKay

    Department of Biological Sciences, Stanford Universitiy, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Daniel P Riordan

    Department of Biochemistry, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Natalie Kofler

    Columbia University Medical Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Jan Kitajewski

    Columbia University Medical Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Irving Weissman

    Institute for Stem Cell and Regenerative Medicine, Ludwig Center, Stanford School of Medicine, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Kristy Red-Horse

    Department of Biological Sciences, Stanford University, Stanford, United States
    For correspondence
    kredhors@stanford.edu
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Giulio Cossu, University of Manchester, United Kingdom

Ethics

Animal experimentation: All animal experiments were performed according to protocols approved by the Stanford University Institutional Animal Care and Use Committee (IACUC) under the protocol #26923 (Assurance #A3213-01). The laboratory animal care program at Stanford University is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC).

Version history

  1. Received: July 13, 2015
  2. Accepted: October 12, 2015
  3. Accepted Manuscript published: October 19, 2015 (version 1)
  4. Version of Record published: December 23, 2015 (version 2)

Copyright

© 2015, Volz et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,019
    Page views
  • 1,413
    Downloads
  • 142
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Katharina S Volz
  2. Andrew H Jacobs
  3. Heidi I Chen
  4. Aruna Poduri
  5. Andrew S McKay
  6. Daniel P Riordan
  7. Natalie Kofler
  8. Jan Kitajewski
  9. Irving Weissman
  10. Kristy Red-Horse
(2015)
Pericytes are progenitors for coronary artery smooth muscle
eLife 4:e10036.
https://doi.org/10.7554/eLife.10036

Share this article

https://doi.org/10.7554/eLife.10036

Further reading

    1. Developmental Biology
    2. Neuroscience
    Tariq Zaman, Daniel Vogt ... Michael R Williams
    Research Article

    The cell-type-specific expression of ligand/receptor and cell-adhesion molecules is a fundamental mechanism through which neurons regulate connectivity. Here, we determine a functional relevance of the long-established mutually exclusive expression of the receptor tyrosine kinase Kit and the trans-membrane protein Kit Ligand by discrete populations of neurons in the mammalian brain. Kit is enriched in molecular layer interneurons (MLIs) of the cerebellar cortex (i.e., stellate and basket cells), while cerebellar Kit Ligand is selectively expressed by a target of their inhibition, Purkinje cells (PCs). By in vivo genetic manipulation spanning embryonic development through adulthood, we demonstrate that PC Kit Ligand and MLI Kit are required for, and capable of driving changes in, the inhibition of PCs. Collectively, these works in mice demonstrate that the Kit Ligand/Kit receptor dyad sustains mammalian central synapse function and suggest a rationale for the affiliation of Kit mutation with neurodevelopmental disorders.

    1. Developmental Biology
    2. Neuroscience
    Smrithi Prem, Bharati Dev ... Emanuel DiCicco-Bloom
    Research Article

    Autism spectrum disorder (ASD) is defined by common behavioral characteristics, raising the possibility of shared pathogenic mechanisms. Yet, vast clinical and etiological heterogeneity suggests personalized phenotypes. Surprisingly, our iPSC studies find that six individuals from two distinct ASD-subtypes, idiopathic and 16p11.2 deletion, have common reductions in neural precursor cell (NPC) neurite outgrowth and migration even though whole genome sequencing demonstrates no genetic overlap between the datasets. To identify signaling differences that may contribute to these developmental defects, an unbiased phospho-(p)-proteome screen was performed. Surprisingly despite the genetic heterogeneity, hundreds of shared p-peptides were identified between autism subtypes including the mTOR pathway. mTOR signaling alterations were confirmed in all NPCs across both ASD-subtypes, and mTOR modulation rescued ASD phenotypes and reproduced autism NPC associated phenotypes in control NPCs. Thus, our studies demonstrate that genetically distinct ASD subtypes have common defects in neurite outgrowth and migration which are driven by the shared pathogenic mechanism of mTOR signaling dysregulation.